Register to receive a free Orthopedic Large Joint Replacement Devices Market Report Suite for US 2016 – 2022 report synopsis and brochure
Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and quality of care for patients, recently announced the initiation of a Multi-Center Prospective Study in Primary Total Hip Arthroplasty for its lead hip replacement system, the HRS. Total hip arthroplasty is commonly referred to as total hip replacement.
The objective of the clinical trial is to evaluate the effectiveness and safety of the HRS hip replacement system in 100 – 120 patients receiving a total hip arthroplasty (THA). Effectiveness will be evaluated using clinical, radiologic, radiostereometric and patient-reported outcomes. Safety will be assessed through the collection of device-related adverse events. Patient quality of life metrics will also be closely monitored.
“The HRS is a unique hip implant design that we believe represents breakthrough technology and a significant advancement for patients requiring total hip arthroplasty,” said George Diamantoni, Hip Innovation Technology’s Co-Founder and Chief Executive Officer. “We look forward to confirming potential differentiating clinical benefits including hip stability at extended ranges of motion, reduced risk of device dislocation and greater latitude for placement of hip components relative to the current designs.”
The company has extensively tested the HRS in over 80 standard and unique pre-clinical experiments to assess the product safety and clinical benefits anticipated by the unique system design.
“The bench level data compiled for the HRS is more extensive than any that I have reviewed for currently marketed hip implant systems,” said Thomas Turgeon, MD, Chief Medical Officer of the Orthopaedic Innovation Centre, and Orthopaedic Surgeon at Concordia Joint Replacement Group. “I am impressed with the unique system design. I look forward to assessing its clinical performance, and am hopeful that many patients will benefit from this novel device.”
Total hip replacements are one of the most effective ways to reduce joint pain and improve functioning for patients with advanced hip problems. During the 2015 calendar year, approximately 324,000 surgeries were performed in the U.S. and 50,000 in Canada.
For Further Information
More on the orthopedic large joint market in the U.S. can be found in a series of reports published by iData Research entitled the US Market for Orthopedic Large Joint Replacement Devices. The suite covers reports on the following markets: Knee Replacement Devices, Hip Replacement Devices and Bone Cements.
The iData report series on orthopedic large joint devices covers the U.S., China, India, Japan, Australia, South Korea, Brazil and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about orthopedic large joint devices market data or procedure data, register online or email us at firstname.lastname@example.org for a US Market for Orthopedic Large Joint Replacement Devices brochure and synopsis.